Dosimetric Analysis of the Short-Ranged Particle Emitter (161)Tb for Radionuclide Therapy of Metastatic Prostate Cancer

SIMPLE SUMMARY: A tremendous effort and rapid development of the prostate-specific membrane antigen (PSMA)-targeting radio ligands for radionuclide therapy has resulted in encouraging response rates for advanced prostate cancer. Different radionuclides have been utilized or suggested as suitable can...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernhardt, Peter, Svensson, Johanna, Hemmingsson, Jens, van der Meulen, Nicholas P., Zeevaart, Jan Rijn, Konijnenberg, Mark W., Müller, Cristina, Kindblom, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122331/
https://www.ncbi.nlm.nih.gov/pubmed/33921956
http://dx.doi.org/10.3390/cancers13092011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122331/
https://www.ncbi.nlm.nih.gov/pubmed/33921956
http://dx.doi.org/10.3390/cancers13092011

Ejemplares similares